Trump announces US drug pricing deal with AstraZeneca

STORY: :: Trump says AstraZeneca will sell some medicines to the U.S. at discounted prices:: October 10, 2025:: Washington, D.C."Today, AstraZeneca is committing to offer all of their prescription medications to Medicaid at most favored nations prices. In other words, the lowest price anywhere in the world. That's what we get. A move that will save American taxpayers hundreds of millions of dollars each year. // In addition, all medications AstraZeneca introduces to the American market going forward will also be sold at these heavily discounted rates. Furthermore, AstraZeneca will invest $50 billion in the United States over the next five years for research and development of new drugs and to onshore manufacturing facilities across the country..."U.S. patients currently pay by far the most for prescription medicines, often nearly three times more than in other developed nations, and Trump has been pressuring drugmakers to lower their prices to what patients pay elsewhere or face stiff tariffs.Last month, he threatened 100% tariffs, ratcheting up pressure on the pharmaceutical industry to agree to price cuts and shift manufacturing to the U.S., after negotiations broke down earlier this year, lobbyists and executives told Reuters following the Pfizer deal.

View Comments